封面
市場調查報告書
商品編碼
1918342

異麥芽寡醣市場-2026-2031年預測

Isomalto-oligosaccharide Market - Forecast from 2026 to 2031

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計在預測期內,異麥芽寡醣市場將以穩定的速度成長。

異麥芽寡醣(IMO) 是一種高麥芽糖漿,由多種短鏈碳水化合物混合而成,因其在健康加工食品(尤其是蛋白棒)生產中備受青睞而聲名鵲起。其市場定位主要得益於其甜美的口感,並宣稱其是一種零卡路里益生元纖維,對血糖值的影響極小。除了營養領域,機能性寡糖也應用於製藥、化妝品、農業化學品配方和包封技術,展現了其在各個工業領域的廣泛效用。

功能優勢與應用領域

異麥芽酮糖醇(IMO)透過促進有益菌的生長,在維持健康的腸道環境方面發揮重要作用。它獨特的特性是不會引起血糖值飆升,因此是糖尿病患者或注重體重管理人士的理想選擇。 IMO 的甜味和質地使其成為獨特的低熱量糖替代品。其益生元特性不僅適用於人類,也適用於飼料,有助於牲畜的健康和生長。

各大品牌正積極將異麥芽寡糖(IMO)作為低熱量甜味劑添加到能量棒和其他產品中,以最大限度地減少對血糖值的影響,從而支持糖尿病患者的飲食。製造商正在透過添加益生元纖維來拓展其機能性食品產品線,而飼料公司則致力於改善動物營養,以促進牲畜健康。低聚半乳寡糖的功能性益處有助於改善健康,包括降低血液膽固醇和三酸甘油酯水平,以及增強食物中礦物質的吸收。

適用於多個行業

異麥芽寡醣用途廣泛,可用於多種食品和飲料,包括巧克力、烘焙點心、冰淇淋和優格。異麥芽寡糖具有易於消化、營養豐富的特性(低甜度、低熱量、低滲透壓),因此廣泛應用於食品加工、飲料、乳製品、果汁、果醬、蛋糕、葡萄酒和機能性食品等領域。作為一種益生元,異麥芽寡糖已被證實能夠促進大腸內有益菌的生長,從而改善消化系統健康和免疫功能。

在製藥領域,異麥芽寡醣作為藥物製劑的添加劑受到監管,對藥物的研發和配製有重要作用。機能性寡糖的多功能性也延伸至化妝品和農藥領域,展現了其在各種工業用途的適應性。

市場挑戰

異麥芽寡醣(IMO) 的定價十分複雜,受多種因素影響,主要包括原料供應狀況及相關生產成本。 IMO 生產所用原料(例如木薯粉、有機木薯粉和玉米粉)的供應量會因農業狀況、季節性波動和市場需求而波動。此外,生產過程中的相關成本,包括酵素加工、液化、濃縮和乾燥等,也對最終價格起著重要作用。能源成本、人事費用和其他營運費用也計入生產成本,進而影響最終市場價格。然而,整體市場成長和供應鏈穩定可能有助於未來市場價格的穩定。

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 異麥芽低聚醣市場依形式分類

  • 介紹
  • 粉末
  • 糖漿/液體

6. 異麥芽寡糖市場(依應用領域分類)

  • 介紹
  • 食物
  • 製藥
  • 其他

7. 異麥芽低聚醣市場(依化學類型分類)

  • 介紹
  • 寡果醣
  • 麥芽寡糖
  • 其他

8. 異麥芽寡糖市場(依地區分類)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • Baolingbao Biology Co., Ltd.
  • Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
  • Nihon Shokuhin Kako Co., Ltd.
  • SHOWA Corporation
  • BioNeutra North America, Inc.
  • Van Wankum Ingredients
  • Qingdao Bailong Huichuang Bio-Tech Co., Ltd.
  • Shandong Shine Health Co., Ltd.
  • Guangzhou Hisoya Biological Science & Technology Co., Ltd.
  • Anhui Elite Industrial Co., Ltd.
  • COFCO Rongshi Biotechnology Co., Ltd.
  • Jiangxi E&C Sugar Alcohol Co., Ltd.

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061616356

The isomalto-oligosaccharide market is anticipated to expand at a steady rate during the forecast period.

Isomalto-oligosaccharide (IMO) stands out as a high-maltose syrup composed of a blend of short-chain carbohydrates, gaining significant acclaim as a sought-after ingredient particularly in creating health-focused processed foods such as protein bars. Its market positioning emphasizes sweet taste coupled with claims of being a zero-calorie prebiotic fiber with minimal impact on blood sugar levels. Beyond nutrition, functional oligosaccharides find applications in pharmaceuticals, cosmetics, agrichemical formulations, and encapsulation technology, showcasing their versatility and widespread utility across diverse industries.

Functional Benefits and Applications

IMO plays a pivotal role in promoting gut health by fostering growth of beneficial bacteria. Its unique attribute of not causing blood sugar spikes makes it a suitable choice for individuals managing diabetes and those focused on weight management. Offering sweetness and texture, IMO stands out as a lower-calorie alternative to sugar. The prebiotic property extends beyond human applications to include animal feeds, contributing to health and growth of farm animals.

Brands are increasingly using IMO for low-calorie sweetness in bars and other products, supporting diabetic diets by minimizing blood sugar impact. Manufacturers are expanding functional foods by adding prebiotic fiber, while feed makers are enhancing animal nutrition to improve livestock health. The functional benefits of galactooligosaccharides contribute to health improvements including reduction of blood cholesterol and triglycerides, and assistance in absorption of minerals from foods.

Versatility Across Industries

Isomalto-oligosaccharides showcase remarkable versatility in usage across various foods and beverages, spanning chocolates, baked goods, ice cream, and yogurt. Malto-oligosaccharides, characterized by digestible nutrient sweetener properties with low sweetness, calorie content, and osmotic pressure, find diverse applications in food processing, beverages, dairy products, juices, jams, cakes, wines, and functional foods. As prebiotics, they have demonstrated ability to promote growth of beneficial bacteria in the colon, contributing to digestive health and immunity.

In the pharmaceutical sector, isomalt-oligosaccharides are regulated as excipients for drug formulations, contributing to development and formulation of pharmaceutical products. The versatility of functional oligosaccharides extends to cosmetics and agrochemicals, demonstrating their adaptability across multiple industrial applications.

Market Challenges

The pricing of IMO is intricately tied to several factors, primarily availability of raw materials and associated production costs. Raw materials used in IMO production, such as tapioca, organic tapioca, and corn starch, can experience fluctuations in availability due to agricultural conditions, seasonal variations, and market demand. Additionally, costs associated with the production process, including enzyme processing, liquefaction, concentration, and drying, play significant roles in determining overall pricing. Energy costs, labor expenses, and other operational overheads contribute to production costs, which influence final market pricing. However, overall market development and supply chain stability could help stabilize the market over time.

Market Segmentation

The IMO market is segmented into food, pharmaceutical, and others by applications. In the food industry, isomalt-oligosaccharides find extensive use, contributing to sweetness and texture in low-calorie food formulations. Recognized as regulated food additives, they serve as valuable ingredients. Moving beyond the culinary domain, these oligosaccharides play significant roles in pharmaceutical sectors as regulated excipients for drug formulations. Moreover, they exhibit versatility in cosmetics and agricultural chemicals sectors.

Regional Market Analysis

North America is projected to account for notable market share, underscored by the region's substantial prevalence of overweight and obesity. With significant portions of the adult population categorized as overweight or obese, the market for health-conscious ingredients is positioned for growth. IMO's perceived role as a prebiotic fiber source, believed to have minimal impact on net carbohydrate value of food products, positions it as an appealing choice for those seeking "low-carb" options. This characteristic aligns with prevalent consumer demand for healthier alternatives, making North America a key market for IMO. Obesity concerns are driving demand in the region, supporting market expansion.

Product Offerings

Market products are available in various forms including powder and syrup. Specialized manufacturing processes involve converting molecules from sources like corn, wheat, barley, potatoes, or tapioca into functional IMO molecules. Products derived from refined tapioca, organic tapioca, and corn starch undergo enzyme treatment, liquefaction, concentration, and drying, resulting in exceptional quality positioning as excellent prebiotics. These products find wide utilization across industries including animal husbandry, medical treatment, and daily health care, employed in formulation of high-purity health products. Functioning as functional healthcare products and healthy, low-calorie sweeteners, they uniquely emphasize prebiotic advantages, making them particularly suitable for individuals with intestinal concerns and showcasing versatility in catering to diverse health needs.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Isomalt-O-Oligosaccharide Market Segmentation

By Form

  • Powder
  • Syrup / Liquid

By Applications

  • Food
  • Pharmaceutical
  • Others

By Chemical Type

  • Fructo Oligosaccharide
  • Malt Oligosaccharide
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ISOMALT-O-OLIGOSACCHARIDE MARKET BY FORM

  • 5.1. Introduction
  • 5.2. Powder
  • 5.3. Syrup / Liquid

6. ISOMALT-O-OLIGOSACCHARIDE MARKET BY APPLICATIONS

  • 6.1. Introduction
  • 6.2. Food
  • 6.3. Pharmaceutical
  • 6.4. Others

7. ISOMALT-O-OLIGOSACCHARIDE MARKET BY CHEMICAL TYPE

  • 7.1. Introduction
  • 7.2. Fructo Oligosaccharide
  • 7.3. Malt Oligosaccharide
  • 7.4. Others

8. ISOMALT-O-OLIGOSACCHARIDE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Baolingbao Biology Co., Ltd.
  • 10.2. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
  • 10.3. Nihon Shokuhin Kako Co., Ltd.
  • 10.4. SHOWA Corporation
  • 10.5. BioNeutra North America, Inc.
  • 10.6. Van Wankum Ingredients
  • 10.7. Qingdao Bailong Huichuang Bio-Tech Co., Ltd.
  • 10.8. Shandong Shine Health Co., Ltd.
  • 10.9. Guangzhou Hisoya Biological Science & Technology Co., Ltd.
  • 10.10. Anhui Elite Industrial Co., Ltd.
  • 10.11. COFCO Rongshi Biotechnology Co., Ltd.
  • 10.12. Jiangxi E&C Sugar Alcohol Co., Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations